Royal Bank of Canada
MDWD icon

Royal Bank of Canada’s MediWound MDWD Stock Holding History

Royal Bank of Canada’s Portfolio MDWD Stock Details MDWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4K Sell
236
-80
-25% -$1.39K ﹤0.01% 6502
2025
Q4 		$5K Sell
316
-228
-42% -$4.17K ﹤0.01% 6718
2025
Q3 		$10K Buy
+544
New +$10K ﹤0.01% 6481
2025
Q2 		– Sell
-2,163
Closed -$33K – 7216
2025
Q1 		$33K Sell
2,163
-1,000
-32% -$17.9K ﹤0.01% 5731
2024
Q4 		$57K Buy
3,163
+57
+2% +$983 ﹤0.01% 5623
2024
Q3 		$56K Buy
3,106
+2,353
+312% +$42.9K ﹤0.01% 5647
2024
Q2 		$12K Buy
753
+748
+14,960% +$12.4K ﹤0.01% 6273
2024
Q1 		$0 Sell
5
-46
-90% -$630 ﹤0.01% 7350
2023
Q4 		$1K Buy
51
+50
+5,000% +$449 ﹤0.01% 6949
2023
Q3 		$0 Sell
1
-22
-96% -$202 ﹤0.01% 7363
2023
Q2 		$0 Buy
+23
New +$248 ﹤0.01% 7487
2023
Q1 		– Sell
-7
Closed – – 7310
2022
Q4 		$0 Sell
7
-72
-91% -$729 ﹤0.01% 7519
2022
Q3 		$1K Buy
79
+37
+88% +$466 ﹤0.01% 7219
2022
Q2 		$1K Sell
42
-18
-30% -$238 ﹤0.01% 7153
2022
Q1 		$1K Buy
+60
New +$972 ﹤0.01% 7605

Other funds holding MDWD

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada's MDWD Position: Q1 2026 in Review

Royal Bank of Canada reduced its MediWound (MDWD) stake by 25% in Q1 2026, selling an estimated $1.39K and leaving 236 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #6502.

Royal Bank of Canada first reported a position in MDWD in Q1 2022 and has held it in 15 quarters since. The position peaked at $57K in Q4 2024. 76 funds tracked by Wall St. Rank hold MDWD as of Q1 2026.

  • Royal Bank of Canada held 236 shares of MediWound worth $4K as of Q1 2026.
  • Royal Bank of Canada sold 80 MediWound shares in Q1 2026, an estimated $1.39K.
  • MediWound made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6502 holding.
  • Royal Bank of Canada first reported a position in MediWound in Q1 2022 and has held it in 15 quarters since.
  • Royal Bank of Canada's MediWound position peaked at $57K in Q4 2024.
  • 76 funds tracked by Wall St. Rank held MediWound as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.